Published in J Gen Virol on July 01, 1995
Herpesvirus assembly and egress. J Virol (2002) 6.39
Ultrastructural localization of the herpes simplex virus type 1 UL31, UL34, and US3 proteins suggests specific roles in primary envelopment and egress of nucleocapsids. J Virol (2002) 3.45
Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine. Microbiol Mol Biol Rev (2005) 3.06
Herpes simplex virus type 1 U(L)34 gene product is required for viral envelopment. J Virol (2000) 3.06
Primary envelopment of pseudorabies virus at the nuclear membrane requires the UL34 gene product. J Virol (2000) 2.91
Comprehensive characterization of extracellular herpes simplex virus type 1 virions. J Virol (2008) 2.30
The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc Natl Acad Sci U S A (1998) 2.22
The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J Virol (2003) 2.21
Herpes simplex virus type 1 primary envelopment: UL34 protein modification and the US3-UL34 catalytic relationship. J Virol (2004) 2.01
The UL48 tegument protein of pseudorabies virus is critical for intracytoplasmic assembly of infectious virions. J Virol (2002) 1.97
Role of pseudorabies virus Us9, a type II membrane protein, in infection of tissue culture cells and the rat nervous system. J Virol (2000) 1.97
Vesicle formation from the nuclear membrane is induced by coexpression of two conserved herpesvirus proteins. Proc Natl Acad Sci U S A (2007) 1.93
US3 of herpes simplex virus type 1 encodes a promiscuous protein kinase that phosphorylates and alters localization of lamin A/C in infected cells. J Virol (2007) 1.78
Subversion of the actin cytoskeleton during viral infection. Nat Rev Microbiol (2011) 1.77
Differing roles of inner tegument proteins pUL36 and pUL37 during entry of herpes simplex virus type 1. J Virol (2008) 1.60
Roles for herpes simplex virus type 1 UL34 and US3 proteins in disrupting the nuclear lamina during herpes simplex virus type 1 egress. Virology (2006) 1.53
Herpesvirus interactions with the host cytoskeleton. J Virol (2008) 1.43
Emerin is hyperphosphorylated and redistributed in herpes simplex virus type 1-infected cells in a manner dependent on both UL34 and US3. J Virol (2007) 1.41
The pseudorabies virus US3 protein is a component of primary and of mature virions. J Virol (2004) 1.39
Herpes simplex virus 1-encoded protein kinase UL13 phosphorylates viral Us3 protein kinase and regulates nuclear localization of viral envelopment factors UL34 and UL31. J Virol (2006) 1.33
Functional characterization of Kaposi's sarcoma-associated herpesvirus ORF45 by bacterial artificial chromosome-based mutagenesis. J Virol (2006) 1.29
The varicella-zoster virus ORF66 protein induces kinase activity and is dispensable for viral replication. J Virol (1996) 1.29
Insertions in the gG gene of pseudorabies virus reduce expression of the upstream Us3 protein and inhibit cell-to-cell spread of virus infection. J Virol (2001) 1.27
Herpesvirus gB-induced fusion between the virion envelope and outer nuclear membrane during virus egress is regulated by the viral US3 kinase. J Virol (2009) 1.27
Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus. J Virol (2007) 1.23
Pseudorabies virus US3 protein kinase mediates actin stress fiber breakdown. J Virol (2003) 1.21
Conserved herpesvirus protein kinases. Biochim Biophys Acta (2007) 1.17
Glycoproteins required for entry are not necessary for egress of pseudorabies virus. J Virol (2008) 1.14
The attenuated pseudorabies virus strain Bartha fails to package the tegument proteins Us3 and VP22. J Virol (2003) 1.11
Two viral kinases are required for sustained long distance axon transport of a neuroinvasive herpesvirus. Traffic (2008) 1.04
The pseudorabies virus Us2 protein, a virion tegument component, is prenylated in infected cells. J Virol (2003) 1.04
Role of tegument proteins in herpesvirus assembly and egress. Protein Cell (2010) 1.02
A physical link between the pseudorabies virus capsid and the nuclear egress complex. J Virol (2011) 1.01
The equine herpesvirus 1 Us2 homolog encodes a nonessential membrane-associated virion component. J Virol (1999) 1.01
Analysis of filamentous process induction and nuclear localization properties of the HSV-2 serine/threonine kinase Us3. Virology (2009) 1.00
Viral serine/threonine protein kinases. J Virol (2010) 0.99
Varicella-zoster virus open reading frame 66 protein kinase is required for efficient viral growth in primary human corneal stromal fibroblast cells. J Virol (2008) 0.97
Herpes simplex virus 1 protein kinase US3 hyperphosphorylates p65/RelA and dampens NF-κB activation. J Virol (2014) 0.96
Nuclear envelope breakdown can substitute for primary envelopment-mediated nuclear egress of herpesviruses. J Virol (2011) 0.95
Herpes simplex virus 1 serine/threonine kinase US3 hyperphosphorylates IRF3 and inhibits beta interferon production. J Virol (2013) 0.95
Role of pseudorabies virus Us3 protein kinase during neuronal infection. J Virol (2006) 0.95
The herpes simplex virus 2 UL21 protein is essential for virus propagation. J Virol (2013) 0.91
Actin in herpesvirus infection. Viruses (2011) 0.90
Directional spread of alphaherpesviruses in the nervous system. Viruses (2013) 0.88
Varicella-zoster virus open reading frame 66 protein kinase and its relationship to alphaherpesvirus US3 kinases. Curr Top Microbiol Immunol (2010) 0.86
Analysis of the early steps of herpes simplex virus 1 capsid tegumentation. J Virol (2013) 0.85
Reconstitution of herpes simplex virus type 1 nuclear capsid egress in vitro. J Virol (2006) 0.84
Pseudorabies virus UL3 gene codes for a nuclear protein which is dispensable for viral replication. J Virol (2004) 0.83
Herpes simplex virus 1 Us3 deletion mutant is infective despite impaired capsid translocation to the cytoplasm. Viruses (2015) 0.81
The alphaherpesvirus serine/threonine kinase us3 disrupts promyelocytic leukemia protein nuclear bodies. J Virol (2011) 0.81
Role of group A p21-activated kinases in the anti-apoptotic activity of the pseudorabies virus US3 protein kinase. Virus Res (2010) 0.80
Herpes simplex virus protein kinases US3 and UL13 modulate VP11/12 phosphorylation, virion packaging, and phosphatidylinositol 3-kinase/Akt signaling activity. J Virol (2014) 0.79
The Us2 gene product of herpes simplex virus 2 is a membrane-associated ubiquitin-interacting protein. J Virol (2013) 0.77
Subcellular localization of the alphaherpesvirus serine/threonine kinase Us3 as a determinant of Us3 function. Virulence (2010) 0.77
Glycoproteins gB and gH are required for syncytium formation but not for herpesvirus-induced nuclear envelope breakdown. J Virol (2013) 0.76
Integrity of the linker of nucleoskeleton and cytoskeleton is required for efficient herpesvirus nuclear egress. J Virol (2017) 0.75
The crystal structure of DNA mismatch repair protein MutS binding to a G x T mismatch. Nature (2000) 6.10
Mystery swine disease in The Netherlands: the isolation of Lelystad virus. Vet Q (1991) 5.36
Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol (1999) 3.74
The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J Biol Chem (1987) 3.55
Pseudorabies virus envelope glycoproteins gp50 and gII are essential for virus penetration, but only gII is involved in membrane fusion. J Virol (1992) 2.93
Immunity to poliomyelitis in The Netherlands. Am J Epidemiol (2001) 2.60
Identification of five allelic variants of the sheep PrP gene and their association with natural scrapie. J Gen Virol (1995) 2.55
Isolation of a TGE virus-related respiratory coronavirus causing fatal pneumonia in pigs. Vet Rec (1989) 2.55
Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus. Virology (1975) 2.55
Synthesis of Rauscher murine leukemia virus-specific polypeptides in vitro. Proc Natl Acad Sci U S A (1976) 2.36
Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. J Gen Virol (1999) 2.23
Chicken anemia virus causes apoptosis of thymocytes after in vivo infection and of cell lines after in vitro infection. J Virol (1992) 1.98
Virus-specific messenger RNA on free and membrane-bound polyribosomes from cells infected with Rauscher leukemia virus. Proc Natl Acad Sci U S A (1974) 1.93
Contribution of single genes within the unique short region of Aujeszky's disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity. J Gen Virol (1992) 1.90
Newcastle disease outbreaks in recent years in western Europe were caused by an old (VI) and a novel genotype (VII). Arch Virol (1998) 1.76
The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol Cell Biol (1999) 1.70
Hypermutation of immunoglobulin genes in memory B cells of DNA repair-deficient mice. J Exp Med (1998) 1.63
Experimental quantification of vaccine-induced reduction in virus transmission. Vaccine (1994) 1.59
Identification of two genes in the unique short region of pseudorabies virus; comparison with herpes simplex virus and varicella-zoster virus. J Gen Virol (1990) 1.57
Glycoprotein H of pseudorabies virus is essential for entry and cell-to-cell spread of the virus. J Virol (1992) 1.57
Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. J Steroid Biochem Mol Biol (2001) 1.53
A simple method for the purification of 5-aminosalicylic acid. Application of the product as substrate in enzyme-linked immunosorbent assay (ELISA). J Immunol Methods (1980) 1.48
Improved detection of rhinoviruses in clinical samples by using a newly developed nested reverse transcription-PCR assay. J Clin Microbiol (1999) 1.46
Site-directed mutagenesis of the Escherichia coli chromosome near oriC: identification and characterization of asnC, a regulatory element in E. coli asparagine metabolism. Nucleic Acids Res (1985) 1.45
Identification of Rauscher murine leukemia virus-specific mRNAs for the synthesis of gag- and env-gene products. Proc Natl Acad Sci U S A (1977) 1.43
Repeats in an extracellular protein of weakly pathogenic strains of Streptococcus suis type 2 are absent in pathogenic strains. Infect Immun (1993) 1.43
Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. J Immunol (1999) 1.42
A lectin from elder (Sambucus nigra L.) bark. Biochem J (1984) 1.40
Cloning and nucleotide sequence of the gene encoding the 136-kilodalton surface protein (muramidase-released protein) of Streptococcus suis type 2. Infect Immun (1992) 1.38
High-efficiency transformation and gene inactivation in Streptococcus suis type 2. Microbiology (1995) 1.36
Glycoprotein gE-negative pseudorabies virus has a reduced capability to infect second- and third-order neurons of the olfactory and trigeminal routes in the porcine central nervous system. J Gen Virol (1994) 1.36
Genome differences among field isolates and vaccine strains of pseudorabies virus. J Gen Virol (1985) 1.35
Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies. J Clin Microbiol (1987) 1.35
Dissection of promoter sequences involved in transcriptional activation of the Escherichia coli replication origin. Nucleic Acids Res (1986) 1.31
Cytolysins of Actinobacillus pleuropneumoniae serotype 9. Infect Immun (1991) 1.29
Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. Mol Endocrinol (1999) 1.25
Genome replication of Newcastle disease virus: involvement of the rule-of-six. Arch Virol (2000) 1.25
An indirect enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to maedi-visna virus. Vet Microbiol (1982) 1.25
Toxicity of Haemophilus pleuropneumoniae to porcine lung macrophages. Vet Microbiol (1989) 1.23
A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine (1994) 1.21
The neutralizing peroxidase-linked assay for detection of antibody against swine fever virus. Vet Microbiol (1984) 1.20
Biosynthesis, primary structure and molecular cloning of snowdrop (Galanthus nivalis L.) lectin. Eur J Biochem (1991) 1.20
Lelystad virus, the cause of porcine epidemic abortion and respiratory syndrome: a review of mystery swine disease research at Lelystad. Vet Microbiol (1992) 1.19
Stimulation of bone resorption by inflamed nasal mucosa, dermonecrotic toxin-containing conditioned medium from Pasteurella multocida, and purified dermonecrotic toxin from P. multocida. Infect Immun (1987) 1.19
The positively charged structural virus protein (VP1) of foot-and-mouth disease virus (type O1) contains a highly basic part which may be involved in early virus-cell interaction. J Gen Virol (1982) 1.18
The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors. J Biol Chem (1996) 1.15
Deleting two amino acids in glycoprotein gI of pseudorabies virus decreases virulence and neurotropism for pigs, but does not affect immunogenicity. J Gen Virol (1993) 1.15
Analysis of the antibody response to bovine respiratory syncytial virus proteins in calves. J Gen Virol (1989) 1.15
Comparative pathogenesis of three strains of pseudorabies virus in pigs. Microb Pathog (1989) 1.14
Interactions in vivo between the proteins of infectious bursal disease virus: capsid protein VP3 interacts with the RNA-dependent RNA polymerase, VP1. J Gen Virol (2000) 1.13
Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains. Biochem J (1999) 1.13
The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. Am J Pathol (2001) 1.13
Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals. Vaccine (2001) 1.13
Change of specificity mutations in androgen-selective enhancers. Evidence for a role of differential DNA binding by the androgen receptor. J Biol Chem (2000) 1.12
Cloning and characterization of the Actinobacillus pleuropneumoniae-RTX-toxin III (ApxIII) gene. Infect Immun (1993) 1.09
Knockout mutants of Actinobacillus pleuropneumoniae serotype 1 that are devoid of RTX toxins do not activate or kill porcine neutrophils. Infect Immun (1995) 1.09
Molecular-biological characterization of Marek's disease virus. I. Identification of virus-specific polypeptides in infected cells. Virology (1982) 1.09
An efficient procedure for the isolation of polyribosomes from tissue culture. Eur J Biochem (1971) 1.07
Induction of nasal turbinate atrophy in germ-free pigs, using Pasteurella multocida as well as bacterium-free crude and purified dermonecrotic toxin of P multocida. Am J Vet Res (1988) 1.07
Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses. J Biol Chem (2000) 1.06
Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element. Mol Endocrinol (1999) 1.06
A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves. J Gen Virol (1994) 1.05
Introduction, persistence and fade-out of porcine reproductive and respiratory syndrome virus in a Dutch breeding herd: a mathematical analysis. Epidemiol Infect (2000) 1.05
Structural analysis of the Actinobacillus pleuropneumoniae-RTX-toxin I (ApxI) operon. Infect Immun (1993) 1.04
Rescue of very virulent and mosaic infectious bursal disease virus from cloned cDNA: VP2 is not the sole determinant of the very virulent phenotype. J Virol (2000) 1.04
Antigenic drift in swine influenza H3 haemagglutinins with implications for vaccination policy. Vaccine (1999) 1.03
Some characteristics of four attenuated vaccine virus strains and a virulent strain of Aujeszky's disease virus. Vet Q (1984) 1.03
Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy. Gene Ther (2007) 1.02
Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology. Infect Immun (2006) 1.02
Isolation and characterization of trypsin-resistant O1 variants of foot-and-mouth disease virus. J Gen Virol (1979) 1.02
Production of monoclonal antibodies directed against antigenic determinants common to the alpha- and beta-chain of bovine brain S-100 protein. Lab Invest (1985) 1.01
Molecular cloning, expression, and characterization of PTPA, a protein that activates the tyrosyl phosphatase activity of protein phosphatase 2A. J Biol Chem (1994) 1.01
Deleting valine-125 and cysteine-126 in glycoprotein gI of pseudorabies virus strain NIA-3 decreases plaque size and reduces virulence in mice. Arch Virol (1993) 1.00
Purification and characterisation of prostatic binding protein and its subunits. Eur J Biochem (1978) 1.00
Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors. Environ Health Perspect (2001) 1.00
Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay. J Gen Virol (1986) 0.99
Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation. J Infect Dis (2004) 0.99
Functional characterization of an androgen response element in the first intron of the C3(1) gene of prostatic binding protein. Biochem Biophys Res Commun (1989) 0.98
Efficient rescue of infectious bursal disease virus from cloned cDNA: evidence for involvement of the 3'-terminal sequence in genome replication. Virology (1999) 0.97
Transient depletion of cortical thymocytes induced by chicken anaemia agent. Thymus (1989) 0.96
Evaluation of B cell lymphoid infiltrates in bone marrow biopsies by morphology, immunohistochemistry, and molecular analysis. J Clin Pathol (2000) 0.94
Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain. J Gen Virol (1990) 0.94
Isolation and partial characterization of an N-acetylgalactosamine-specific lectin from winter-aconite (Eranthis hyemalis) root tubers. Biochem J (1985) 0.94
Immunoglobulin M-specific enzyme-linked immunosorbent assay for serodiagnosis of bovine respiratory syncytial virus infections. Am J Vet Res (1987) 0.93
Transmission of two pseudorabies virus strains that differ in virulence and virus excretion in groups of vaccinated pigs. Am J Vet Res (1996) 0.93
The influence of maternal immunity on the transmission of pseudorabies virus and on the effectiveness of vaccination. Vaccine (1997) 0.93
A quantitative assessment of the effectiveness of PRRSV vaccination in pigs under experimental conditions. Vaccine (2001) 0.93
Isolation and characterization of a 5S RNA-protein complex from human placental ribosomes. Mol Biol Rep (1974) 0.93
Epitope analysis of glycoprotein I of pseudorabies virus. J Gen Virol (1990) 0.93
A mouse model to study immunity against pseudorabies virus infection: significance of CD4+ and CD8+ cells in protective immunity. Vaccine (1998) 0.93
Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity. Fam Cancer (2013) 0.93
Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands. Clin Diagn Lab Immunol (1997) 0.92